Covid-19 vaccine technology can help treat heart attacks

8

Simulation of the human heart and genetic mechanism MIET

In the US alone, about 805,000 people have a heart attack each year and 100,000 in the UK.

A team of experts from King’s College London (KCL-UK) has found the genetic codes responsible for creating proteins that stimulate the production of heart cells, opening the first direction of treatment for heart attack patients. , according to the sheet The New York Times April 16th.

Use mRNA technology (technology to make a vaccine against Covid-19), they hope to successfully research a therapy to treat the risk of heart attack. It is expected that human trials can start in two years.

Lead researcher Professor Mauro Giacca said that the number of heart muscle cells at the time of birth is the same as the number at the time of death.

After a heart attack, the heart is unable to heal or repair itself. So his team’s goal was to find a therapy that would stimulate heart cells to replicate, multiply, and regenerate the organ.

“We are using vaccine technology from Pfizer and Moderna to inject mRNA proteins into the heart, deliver them where the cells are left, and prompt the cells to self-reproduce. New cells will replace the dead cells,” explains Professor Giacca.

In addition, the researchers are extremely excited about the possibility that they can limit the damage to the heart once it occurs. heart attack. In theory, when the protein was injected by the time the ambulance arrived, the patient’s severity could be reduced and the risk of death could be avoided.